GIPR-agonist compounds
The present invention relates to compounds having activity at the human glucose-dependent insulinotropic polypeptide (GIP) receptor. The present invention also relates to compounds having an extended duration of action at the GIP receptor. Such compounds may be useful in the treatment of diabetes, i...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Keyser, Samantha Grace Lyons Guo, Lili Lee, John Qu, Hongchang Alsina-Fernandez, Jorge Roell, William Christopher Geiser, Andrea Renee |
| description | The present invention relates to compounds having activity at the human glucose-dependent insulinotropic polypeptide (GIP) receptor. The present invention also relates to compounds having an extended duration of action at the GIP receptor. Such compounds may be useful in the treatment of diabetes, including type 2 diabetes mellitus ("T2DM"). Also, the compounds may be useful in the treatment of obesity. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US11254721B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US11254721B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US11254721B23</originalsourceid><addsrcrecordid>eNrjZBBz9wwI0k1Mz8_LLC5RSM7PLcgvzUsp5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8aHBhoZGpibmRoZORsbEqAEAiN0haw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>GIPR-agonist compounds</title><source>esp@cenet</source><creator>Keyser, Samantha Grace Lyons ; Guo, Lili ; Lee, John ; Qu, Hongchang ; Alsina-Fernandez, Jorge ; Roell, William Christopher ; Geiser, Andrea Renee</creator><creatorcontrib>Keyser, Samantha Grace Lyons ; Guo, Lili ; Lee, John ; Qu, Hongchang ; Alsina-Fernandez, Jorge ; Roell, William Christopher ; Geiser, Andrea Renee</creatorcontrib><description>The present invention relates to compounds having activity at the human glucose-dependent insulinotropic polypeptide (GIP) receptor. The present invention also relates to compounds having an extended duration of action at the GIP receptor. Such compounds may be useful in the treatment of diabetes, including type 2 diabetes mellitus ("T2DM"). Also, the compounds may be useful in the treatment of obesity.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220222&DB=EPODOC&CC=US&NR=11254721B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220222&DB=EPODOC&CC=US&NR=11254721B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Keyser, Samantha Grace Lyons</creatorcontrib><creatorcontrib>Guo, Lili</creatorcontrib><creatorcontrib>Lee, John</creatorcontrib><creatorcontrib>Qu, Hongchang</creatorcontrib><creatorcontrib>Alsina-Fernandez, Jorge</creatorcontrib><creatorcontrib>Roell, William Christopher</creatorcontrib><creatorcontrib>Geiser, Andrea Renee</creatorcontrib><title>GIPR-agonist compounds</title><description>The present invention relates to compounds having activity at the human glucose-dependent insulinotropic polypeptide (GIP) receptor. The present invention also relates to compounds having an extended duration of action at the GIP receptor. Such compounds may be useful in the treatment of diabetes, including type 2 diabetes mellitus ("T2DM"). Also, the compounds may be useful in the treatment of obesity.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBBz9wwI0k1Mz8_LLC5RSM7PLcgvzUsp5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8aHBhoZGpibmRoZORsbEqAEAiN0haw</recordid><startdate>20220222</startdate><enddate>20220222</enddate><creator>Keyser, Samantha Grace Lyons</creator><creator>Guo, Lili</creator><creator>Lee, John</creator><creator>Qu, Hongchang</creator><creator>Alsina-Fernandez, Jorge</creator><creator>Roell, William Christopher</creator><creator>Geiser, Andrea Renee</creator><scope>EVB</scope></search><sort><creationdate>20220222</creationdate><title>GIPR-agonist compounds</title><author>Keyser, Samantha Grace Lyons ; Guo, Lili ; Lee, John ; Qu, Hongchang ; Alsina-Fernandez, Jorge ; Roell, William Christopher ; Geiser, Andrea Renee</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US11254721B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Keyser, Samantha Grace Lyons</creatorcontrib><creatorcontrib>Guo, Lili</creatorcontrib><creatorcontrib>Lee, John</creatorcontrib><creatorcontrib>Qu, Hongchang</creatorcontrib><creatorcontrib>Alsina-Fernandez, Jorge</creatorcontrib><creatorcontrib>Roell, William Christopher</creatorcontrib><creatorcontrib>Geiser, Andrea Renee</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Keyser, Samantha Grace Lyons</au><au>Guo, Lili</au><au>Lee, John</au><au>Qu, Hongchang</au><au>Alsina-Fernandez, Jorge</au><au>Roell, William Christopher</au><au>Geiser, Andrea Renee</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>GIPR-agonist compounds</title><date>2022-02-22</date><risdate>2022</risdate><abstract>The present invention relates to compounds having activity at the human glucose-dependent insulinotropic polypeptide (GIP) receptor. The present invention also relates to compounds having an extended duration of action at the GIP receptor. Such compounds may be useful in the treatment of diabetes, including type 2 diabetes mellitus ("T2DM"). Also, the compounds may be useful in the treatment of obesity.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US11254721B2 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | GIPR-agonist compounds |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T05%3A22%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Keyser,%20Samantha%20Grace%20Lyons&rft.date=2022-02-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS11254721B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |